(Q44330324)

English

Enhanced analgesic potency and reduced tolerance of morphine in 129/SvEv mice: evidence for a deficiency in GM1 ganglioside-regulated excitatory opioid receptor functions

scientific article published in February 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Enhanced analgesic potency and reduced tolerance of morphine in 129/SvEv mice: evidence for a deficiency in GM1 ganglioside-regulated excitatory opioid receptor functions (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Crain SM

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Shen K

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

language of work or name

0 references

publication date

1 February 2000

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

856

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

227-235

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902446-4

7 January 2021

Where is the locus in opioid withdrawal?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902446-4

7 January 2021

After chronic opioid exposure sensory neurons become supersensitive to the excitatory effects of opioid agonists and antagonists as occurs after acute elevation of GM1 ganglioside

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902446-4

7 January 2021

Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902446-4

7 January 2021

Chronic morphine-treated sensory ganglion neurons remain supersensitive to the excitatory effects of naloxone for months after return to normal culture medium: an in vitro model of 'protracted opioid dependence'.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902446-4

7 January 2021

GM1 ganglioside-induced modulation of opioid receptor-mediated functions

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902446-4

7 January 2021

Modulation of opioid analgesia, tolerance and dependence by Gs-coupled, GM1 ganglioside-regulated opioid receptor functions

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902446-4

7 January 2021

Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902446-4

7 January 2021

The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902446-4

7 January 2021

N-methyl-D-aspartate (NMDA) receptors, mu and kappa opioid tolerance, and perspectives on new analgesic drug development

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902446-4

7 January 2021

Genetic variance in nociception and its relationship to the potency of morphine-induced analgesia in thermal and chemical tests

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902446-4

7 January 2021

Opioid-sparing effects of a low-dose infusion of naloxone in patient-administered morphine sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902446-4

7 January 2021

Narcotic antagonists. 4. Carbon-6 derivatives of N-substituted noroxymorphones as narcotic antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902446-4

7 January 2021

Opioid delta-receptor involvement in supraspinal and spinal antinociception in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902446-4

7 January 2021

Molecular and functional diversity of mammalian Gs-stimulated adenylyl cyclases.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902446-4

7 January 2021

Effects of prophylactic nalmefene on the incidence of morphine-related side effects in patients receiving intravenous patient-controlled analgesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902446-4

7 January 2021

Continuous co-administration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902446-4

7 January 2021

The development of morphine tolerance and dependence is associated with translocation of protein kinase C.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902446-4

7 January 2021

Transgenic studies of pain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902446-4

7 January 2021

Nociceptive and morphine antinociceptive sensitivity of 129 and C57BL/6 inbred mouse strains: implications for transgenic knock-out studies

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902446-4

7 January 2021

The effect of genotype on sensitivity to inflammatory nociception: characterization of resistant (A/J) and sensitive (C57BL/6J) inbred mouse strains

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902446-4

7 January 2021

Heritability of nociception I: responses of 11 inbred mouse strains on 12 measures of nociception

2 references

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902446-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902446-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacological mechanisms of opioid analgesics.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902446-4

7 January 2021

Comparison of naloxonazine and β-funaltrexamine antagonism of μ1 and μ2 opioid actions

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902446-4

7 January 2021

Direct demonstration of the activation of UDP-N-acetylgalactosamine: [GM3]N-acetylgalactosaminyltransferase by cyclic AMP.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902446-4

7 January 2021

Cholera toxin-B subunit blocks excitatory effects of opioids on sensory neuron action potentials indicating that GM1 ganglioside may regulate Gs-linked opioid receptor functions

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902446-4

7 January 2021

Chronic selective activation of excitatory opioid receptor functions in sensory neurons results in opioid 'dependence' without tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902446-4

7 January 2021

Antagonists at excitatory opioid receptors on sensory neurons in culture increase potency and specificity of opiate analgesics and attenuate development of tolerance/dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902446-4

7 January 2021

Specific N- or C-terminus modified dynorphin and beta-endorphin peptides can selectively block excitatory opioid receptor functions in sensory neurons and unmask potent inhibitory effects of opioid agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902446-4

7 January 2021

Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902446-4

7 January 2021

Brief treatment of sensory ganglion neurons with GM1 ganglioside enhances the efficacy of opioid excitatory effects on the action potential

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902446-4

7 January 2021

Chronic morphine administration increases beta-adrenergic receptor kinase (beta ARK) levels in the rat locus coeruleus

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902446-4

7 January 2021

Inhibition of Morphine Tolerance and Dependence by the NMDA Receptor Antagonist MK-801

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902446-4

7 January 2021

The mu opiate receptor as a candidate gene for pain: polymorphisms, variations in expression, nociception, and opiate responses

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902446-4

7 January 2021

GM1 ganglioside modulates prostaglandin E1 stimulated adenylyl cyclase in neuro-2A cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902446-4

7 January 2021

Interaction of the delta-opioid receptor with GM1 ganglioside: conversion from inhibitory to excitatory mode

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902446-4

7 January 2021

The role of GM1 ganglioside in regulating excitatory opioid effects

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902446-4

7 January 2021

Identifiers

10.1016/S0006-8993(99)02446-4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44330324&oldid=2109486389"